{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T02:09:53Z","timestamp":1768097393030,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejvs.2024.05.034","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:28:14Z","timestamp":1716618494000},"page":"510-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patient Factors Influencing Prescription of Antithrombotic Medication After Lower Limb Endovascular Intervention"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2901-6136","authenticated-orcid":false,"given":"Alison","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8019-9827","authenticated-orcid":false,"given":"Saissan","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Hajian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-6213","authenticated-orcid":false,"given":"Sarah","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2024.05.034_bib1","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.05.034_bib2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.05.034_bib3","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono\u00a0or dual antiplatelet therapy\u2014the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejvs.2024.05.034_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.05.034_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.avsg.2022.08.016","article-title":"Variability in antithrombotic therapy after infrainguinal lower extremity bypass","volume":"88","author":"Brahmandam","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/1358863X19880602","article-title":"Practice patterns of dual antiplatelet therapy after lower extremity endovascular interventions","volume":"24","author":"Kim","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2024.05.034_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor\u2019s Choice \u2013 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2020.05.048","article-title":"Atherosclerotic risk and statin use among patients with peripheral artery disease","volume":"76","author":"Colantonio","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.05.034_bib10","first-page":"260","article-title":"Beware of suboptimal medical management of patients with atherosclerosis requiring revascularization","volume":"31","author":"Le Hello","year":"2012","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2024.05.034_bib11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejvs.2022.02.007","article-title":"Gender differences in outpatient peripheral artery disease management in Germany: a population based study 2009\u20132018","volume":"63","author":"Messiha","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055952","article-title":"Analysis of the relationship between sex and prescriptions for guideline-recommended therapy in peripheral arterial disease, in relation to 1-year all-cause mortality: a primary care cohort study","volume":"12","author":"Benson","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2024.05.034_bib13","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.jcin.2020.08.036","article-title":"Predictors of underutilization of medical therapy in patients undergoing endovascular revascularization for peripheral artery disease","volume":"13","author":"Altin","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.05.034_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.avsg.2017.05.030","article-title":"Risk factors for suboptimal utilization of statins and antiplatelet therapy in patients undergoing revascularization for symptomatic peripheral arterial disease","volume":"46","author":"Meltzer","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejvs.2011.12.003","article-title":"Age- and gender-related differences in the use of secondary medical prevention after primary vascular surgery: a nationwide follow-up study","volume":"43","author":"H\u00f8gh","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib16","first-page":"1115","article-title":"Racial and gender disparity in achieving optimal medical therapy for inpatients with peripheral artery disease","volume":"7","author":"Gober","year":"2020","journal-title":"Ann Vasc Med Res"},{"key":"10.1016\/j.ejvs.2024.05.034_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s42155-019-0079-8","article-title":"The CLEAR (Considering Leading Experts\u2019 Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention","volume":"2","author":"Wong","year":"2019","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.ejvs.2024.05.034_bib18","first-page":"37","article-title":"Antiplatelets, statins, and cilostazol in peripheral artery disease: medical therapy is the responsibility of the interventionalist","volume":"10","author":"Vishesh","year":"2013","journal-title":"Vasc Dis Manag"},{"key":"10.1016\/j.ejvs.2024.05.034_bib19","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.05.034_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/17085381211044397","article-title":"Are primary care physicians aware of peripheral artery disease risk reduction and management in the Saudi healthcare transformation era? A health cluster observational study","volume":"30","author":"Alsheikh","year":"2022","journal-title":"Vascular"},{"key":"10.1016\/j.ejvs.2024.05.034_bib21","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.jacc.2021.04.057","article-title":"The ongoing struggle to optimize lipid-lowering therapy in patients with PAD: PADdling in circles","volume":"77","author":"Secemsky","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2024.05.034_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.avsg.2018.11.034","article-title":"Perceptions of Canadian vascular surgeons toward pharmacologic risk reduction in patients with peripheral artery disease: 2018 update","volume":"58","author":"Li","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib23","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCULATIONAHA.112.129692","article-title":"Medical management of peripheral arterial disease: bridging the \u201cgap\u201d?","volume":"126","author":"Owens","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.05.034_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003291","article-title":"Educational interventions to improve prescribing competency: a systematic review","volume":"3","author":"Kamarudin","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2024.05.034_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.avsg.2012.05.001","article-title":"Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures","volume":"27","author":"Allemang","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1472-6963-14-367","article-title":"The use of discrete choice experiments to inform health workforce policy: a systematic review","volume":"14","author":"Mandeville","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejvs.2024.05.034_bib27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10198-018-0954-6","article-title":"How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity","volume":"19","author":"Quaife","year":"2018","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.ejvs.2024.05.034_bib28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12913-017-2433-7","article-title":"Patients\u2019 preferences for primary health care \u2013 a systematic literature review of discrete choice experiments","volume":"17","author":"Kleij","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejvs.2024.05.034_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13561-020-00276-x","article-title":"Using discrete choice experiments to measure preferences for hard to observe choice attributes to inform health policy decisions","volume":"10","author":"Van Den Broek-Altenburg","year":"2020","journal-title":"Health Econ Rev"},{"key":"10.1016\/j.ejvs.2024.05.034_bib30","first-page":"55","article-title":"Using discrete choice experiments to value health care programmes: current practice and future research reflections","volume":"2","author":"Ryan","year":"2003","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.ejvs.2024.05.034_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.115033","article-title":"Prescribing antibiotics: factors driving decision-making in general practice. A discrete choice experiment","volume":"305","author":"Sydenham","year":"2022","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ejvs.2024.05.034_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jamda.2019.12.004","article-title":"Nursing home clinicians\u2019 decision to prescribe antibiotics for a suspected urinary tract infection: findings from a discrete choice experiment","volume":"21","author":"Kistler","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.ejvs.2024.05.034_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force","volume":"16","author":"Reed Johnson","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.ejvs.2024.05.034_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.ejvs.2024.05.034_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.ejvs.2024.05.034_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jval.2018.07.876","article-title":"The internal validity of discrete choice experiment data: a testing tool for quantitative assessments","volume":"22","author":"Johnson","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.ejvs.2024.05.034_bib38","article-title":"Getting the most from CBC","author":"Johnson","year":"2003","journal-title":"Sequim, WA: Sawtooth Software Research Paper Series, Sawtooth Software"},{"key":"10.1016\/j.ejvs.2024.05.034_bib39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hec.1739","article-title":"Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations","volume":"21","author":"Coast","year":"2012","journal-title":"Health Econ"},{"key":"10.1016\/j.ejvs.2024.05.034_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejvs.2020.03.010","article-title":"Antiplatelet and anticoagulant use in randomised trials of patients undergoing endovascular intervention for peripheral arterial disease: systematic review and narrative synthesis","volume":"60","author":"Qureshi","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135692","article-title":"Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis","volume":"10","author":"Katsanos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejvs.2024.05.034_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/2047487316674817","article-title":"The polypill: an effective approach to increasing adherence and reducing cardiovascular event risk","volume":"24","author":"Bramlage","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejvs.2024.05.034_bib43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejvs.2021.12.019","article-title":"The OAC3-PAD risk score predicts major bleeding events one year after hospitalisation for peripheral artery disease","volume":"63","author":"Behrendt","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejvs.2022.07.055","article-title":"External validation of the OAC3-PAD risk score to predict major bleeding events using the prospective GermanVasc cohort study","volume":"64","author":"Peters","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejvs.2023.04.026","article-title":"Nationwide study in France to predict one year major bleeding and validate the OAC3-PAD score in patients undergoing revascularisation for lower extremity arterial disease","volume":"66","author":"Lareyre","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib47","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/aid.2022.0035","article-title":"Preferences among physicians and men who have sex with men (MSM) for a long-acting, removable implant for HIV prevention: a discrete choice study","volume":"38","author":"Tagliaferri Rael","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.ejvs.2024.05.034_bib48","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1080\/09546634.2022.2059052","article-title":"Patient preferences for topical psoriasis treatments: a discrete choice experiment","volume":"33","author":"Hoelker","year":"2022","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.ejvs.2024.05.034_bib49","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/03007995.2020.1790348","article-title":"Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment","volume":"36","author":"Wong","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejvs.2024.05.034_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/1060028015570468","article-title":"Patient preferences for a polypill for the prevention of cardiovascular diseases","volume":"49","author":"Laba","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejvs.2024.05.034_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjspcare-2021-003082","article-title":"Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment","author":"Scotte","year":"2021","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.ejvs.2024.05.034_bib52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/ijpp.12220","article-title":"Impact of falling reimbursement rates on physician preferences regarding drug therapy for osteoarthritis using a discrete choice experiment","volume":"24","author":"Berchi","year":"2016","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.ejvs.2024.05.034_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jvs.2023.04.026","article-title":"Oral factor Xa inhibitor underutilization following lower extremity peripheral vascular intervention","volume":"78","author":"Bhuta","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib54","first-page":"CD005470","article-title":"Tailored interventions to address determinants of practice","volume":"2015","author":"Baker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2024.05.034_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1108\/IJHCQA-08-2016-0119","article-title":"Implementation strategies for guidelines at ICUs: a systematic review","volume":"30","author":"Jordan","year":"2017","journal-title":"Int J Health Care Qual Assur"},{"key":"10.1016\/j.ejvs.2024.05.034_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018271","article-title":"Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals","volume":"8","author":"Nguyen","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejvs.2024.05.034_bib57","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jvs.2023.04.025","article-title":"Optimal medical management in patients undergoing peripheral vascular interventions for chronic limb-threatening ischemia is associated with improved outcomes","volume":"78","author":"Chang","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib58","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40266-023-01015-7","article-title":"Optimising medications in older vascular surgery patients through geriatric co-management","volume":"40","author":"Wang","year":"2023","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejvs.2024.05.034_bib59","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamasurg.2016.0415","article-title":"Efficacy of a guideline-recommended risk-reduction program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease","volume":"151","author":"Hussain","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejvs.2024.05.034_bib60","first-page":"118","article-title":"Nurse-led risk assessment\/management clinics reduce predicted cardiac morbidity and mortality in claudicants","volume":"26","author":"Hatfield","year":"2008","journal-title":"J\u00a0Vasc Nurs"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424004611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588424004611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T21:32:07Z","timestamp":1726608727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588424004611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1078588424004611"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.05.034","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Factors Influencing Prescription of Antithrombotic Medication After Lower Limb Endovascular Intervention","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}